IRCT20200407046981N17招募中未知
Comparative bioequivalence study of single oral dose of Gabapentin 300 mg capsules produced by Daana pharmaceutical Co versus NEURONTIN® (Pfizer company) in 24 healthy males under fasting conditions
Daana pharmaceutical company0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- Male
入选标准
- •The weight limit for each volunteer is between 60 and 100 kg.
- •All volunteers must be non-smokers.
- •They must be healthy in terms of liver, kidney, respiratory system, mental and other general health characteristics that will be assessed.
排除标准
- •Known hypersensitivity or idiosyncratic reaction to Gabapentin or any ingredients.
- •Subjects with BP = 90/60 mm/Hg or BP = 140/90 mm/Hg.
- •Regular smoker who smokes more than ten cigarettes daily.
- •Taking any medicine during two week before dosing.
研究者
相似试验
招募中
不适用
Study of absorption and elimination rate of sitagliptin 50 mg tablets in comparison with standard tablets of Sitagliptin (Xelevia®).En In this study, the disease is not examined. The subject of the study is the bioequivalence study of the Sitagliptin 50 mg of test and reference in healthy volunteers..IRCT20200407046981N15Daana pharmaceutical company24
Unknown
1 期
A Bioequivalence study of a randomized, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Linagliptin Film Coated Tablets 5 mg relative to Trajenta 5 mg film-coated tablets in healthy Thai adult volunteers under fasting conditioHealthy subjectsBioequivalence (Linagliptin) 5 mgTCTR20221212003Mylan Laboratories Limited.36
尚未招募
1 期
A Bioequivalence study of a randomized, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Vildagliptin and Metformin tablets 50/500 mg relative to GALVUS MET (50MG/500 MG) tablets in healthy Thai adult volunteers under fed condition.Healthy subjectsBioequivalence Vildagliptin and Metformin tablets 50/500 mgTCTR20230822002Bio-innova Co., Ltd.48
尚未招募
1 期
A Bioequivalence study of a randomized, single dose, two-way crossover design with two-period, two-treatment, and two-sequence of Lacosamide Film Coated Tablet 100 mg (Test) relative to Vimpat Film Coated Tablet 100 mg (Reference) in healthy Thai adult volunteers under fasting condition.Healthy subjectsBioequivalence Lacosamide Film Coated Tablet 100 mgTCTR20240529004Bio-innova Co., Ltd.30
尚未招募
不适用
Bioequivalence Study of Dolutegravir Sodium Dispersible Tablet 10 mg (Fed)CTRI/2019/06/019953Macleods Pharmaceuticals Ltd